AI assistant
Sending…
ADIAL PHARMACEUTICALS, INC. — Director's Dealing 2024
Nov 18, 2024
35331_dirs_2024-11-18_120f3314-11a6-4607-9ae4-abdca9b520d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK: 0001513525
Period of Report: 2024-11-16
Reporting Person: Shah Vinay (Chief Financial Officer)
More from ADIAL PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 11
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Jan 6
Proxy Solicitation & Information Statement
2026
Jan 6
Regulatory Filings
2025
Dec 23
Regulatory Filings
2025
Dec 19
Regulatory Filings
2025
Dec 18
Regulatory Filings
2025
Dec 12